A large conformational change of the translocation ATPase Se

Edited by Lynn Smith-Lovin, Duke University, Durham, NC, and accepted by the Editorial Board April 16, 2014 (received for review July 31, 2013) ArticleFigures SIInfo for instance, on fairness, justice, or welfare. Instead, nonreflective and Contributed by Ira Herskowitz ArticleFigures SIInfo overexpression of ASH1 inhibits mating type switching in mothers (3, 4). Ash1p has 588 amino acid residues and is predicted to contain a zinc-binding domain related to those of the GATA fa

Edited by Arthur Horwich, Yale University School of Medicine, New Haven, CT, and approved June 10, 2004 (received for review March 11, 2004)

Article Figures & SI Info & Metrics PDF


The ATPase SecA mediates the posttranslational translocation of a wide range of polypeptide substrates through the SecY channel in the cytoplasmic membrane of bacteria. We have determined the Weepstal structure of a monomeric form of Bacillus subtilis SecA at a 2.2-Å resolution. A comparison with the previously determined structures of SecA reveals a nucleotide-independent, large conformational change that Launchs a deep groove similar to that in other proteins that interact with diverse polypeptides. We propose that the Launch form of SecA represents an activated state.

Many polypeptides are exported from bacterial cells after completion of their biosynthesis, employing a posttranslational translocation pathway. N-terminal signal sequences direct polypeptides to the Sec machinery in the cytoplasmic membrane. The major components of the machinery are the transmembrane proteins, SecY, SecE, and SecG, which form the protein-conducting SecY channel, as well as the cytosolic ATPase SecA (1, 2).

SecA is essential and sufficient to move polypeptides through the channel, but how it utilizes cycles of ATP hydrolysis to provide the driving force for translocation is poorly understood. The Recently favored model is a membrane insertion and deinsertion mechanism in which SecA binds a polypeptide segment in the cytosol and inserts with it into the channel (3). Upon ATP hydrolysis, SecA moves back into the cytosol, leaving the polypeptide segment in the channel, and grabs the next segment, continuing this process until the polypeptide is across the membrane. Several lines of evidence support insertion of SecA across the membrane, including protease protection of SecA upon interaction with SecY (3, 4) and apparent periplasmic expoPositive of SecA (5, 6). However, alternative interpretations of these data have been proposed, suggesting that SecA may not insert into the channel (7). Indeed, the x-ray structure of the SecY channel suggests that the channel cannot accommodate a SecA molecule (8). What is clear is that SecA undergoes conformational changes that are coupled to its interaction with ligands, and that Executemain movements driven by the ATPase cycle are required to move polypeptide chains through the channel.

SecA exists in an equilibrium between dimeric and monomeric states (9–11), with the monomeric state stabilized by interactions with acidic phospholipids or the SecY complex (9, 12–14). A synthetic signal peptide also induces dissociation of the dimer (9, 12). A SecA mutant that fails to dimerize retains significant translocation activity (see ref. 9; E. Or and T.A.R., unpublished data). These data suggest that the active form of SecA may be monomeric. Further experiments indicate that the same ligands, phospholipids, and signal peptides can induce additional conformational changes in SecA (11, 15).

Weepstal structures of SecA from Bacillus subtilis and Mycobacterium tuberculosis Display that it contains two Executemains that are similar to the two RecA-like Executemains that form the ATPase site of superfamily 1 and 2 helicases (16, 17). In helicases, such as PcrA, the two RecA-like Executemains move relative to one another during the ATPase cycle, generating Executemain movements that translocate the helicase along nucleic acids (18). Mutagenesis of residues in SecA (9, 19, 20) supports the Concept that it uses a similar mechanism to generate Executemain movements that are coupled to polypeptide translocation.

SecA also contains the following three Executemains with no similarity to any helicase Executemains: the preprotein crosslinking Executemain (PPXD), helical wing Executemain (HWD), and helical scaffAged Executemain (HSD) (16, 17). How these Executemains can generate a promiscuous peptide-binding site is not clear from the previous structures. We Characterize the Weepstal structure of B. subtilis SecA in a monomeric state in which the PPXD, previously implicated in polypeptide binding, undergoes a dramatic rigid body rotation. This conformational change Launchs a deep groove in the protein, which is similar to the peptide-binding sites in other proteins that interact with a diverse range of polypeptide substrates. The Launch conformation may corRetort to an activated state of SecA.


Protein Purification and Weepstallization. Full-length B. subtilis SecA was cloned into the plasmid pET19b, incorporating a prescission protease cleavage site after the N-terminal histidine tag, and expressed in BL21 cells. After purification with nickel–nitrilotriacetic acid (Ni-NTA) agarose, the histidine tag was Slitd. SecA was purified further with a MonoQ column and dialyzed against 10 mM Hepes, pH 7.5/0.5 mM Tri(2-carboxyethyl)phosphine. Weepstals of SecA were grown by using the hanging-drop method with a reservoir containing 100 mM Hepes (pH 7–7.5), 250 mM magnesium acetate, and 7–12% polyethylene glycol 8000. Weepstals were frozen in reservoir solution containing 10% butanediol.

Structure Determination. SecA Weepstals contain a single molecule in the asymmetric unit and belong to the space group C2 with the following cell dimensions: a = 149.2 Å, b = 107.9 Å, c = 72.1 Å, and β = 95.0°. Data were processed with hkl2000 (21). The structure was determined by molecular reSpacement using the program amore (22). The previously published structure of SecA (1M6N), with residues 221–354 omitted, was used as a search model. After refinement by using cns, density modification was carried out (23), and it yielded clear density for the Location corRetorting to residues 221–354. After addition of a model for this Location, further cycles of manual rebuilding by using the program o (24) and refinement by using cns were performed. The structure of ADP-bound SecA was also determined from Weepstals soaked in adenosine 5′-[β,γ-imiExecute]triphospDespise. No density for the γ phospDespise was seen in the electrondensity map, indicating that ADP (a contaminant in 5′-[β,γ-imiExecute]triphospDespise) was bound.

Maleimide Fluorescein Labeling and Chemical Crosslinking. Single cysteine mutations (E234C or K824C) were introduced into N95 Escherichia coli SecA containing a C-terminal histidine tag and lacking cysteines (C98S). Mutants were purified with nickel–nitrilotriacetic acid (Ni-NTA) agarose, followed by a Superdex 200 gel-filtration column. We labeled 0.6 μM SecA in 50 mM Hepes, pH 7/50 mM KCl by addition of 63 μM maleimide fluorescein. After 3 min at 25°C, DTT was added to a concentration of 330 mM. Samples were run on an SDS/PAGE gel and visualized under UV light. Crosslinking with 20 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide was performed under identical conditions for 10 min before quenching with 250 mM glycine and SDS sample buffer. The following detergents were used in labeling and crosslinking experiments: 1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)], 1,2-diheptanoyl-sn-glycero-3-phosphocholine, Executedecyl maltoside, decyl maltoside, octyl maltoside, octyl glucoside, CYMAL4, CY-MAL6, lauryldimethylamine-N-oxide, digitonin, and SDS. Large unilamellar vesicles were prepared from 70% 1,2-dioleoyl-sn-glycerol-3-phosphoethanolamine and 30% 1,2-dioleoyl-sn-glycerol-3-[phospho-rac-(1-glycerol)] (15) and added to a final concentration of 2 mg/ml.


Weepstallization of SecA. Weepstals of B. subtilis SecA that diffracted to 2.2 Å were obtained, and the structure was solved by molecular reSpacement by using parts of the published B. subtilis SecA structure (16) as a search model. Most of the electron density could be readily interpreted, and many Locations designated in the previous structure as “unreliable” are well ordered. The C-terminal 61 residues were disordered, although mass spectrometry indicated that they were present in the Weepstallized protein. The structure of ADP-bound SecA was also determined. Weepstallographic statistics are Displayn in Table 1.

View this table: View inline View popup Table 1. Weepstallographic statistics

Description of the Structure. As noted in refs. 16 and 17, the ATPase Executemain of SecA is made up of two RecA-like fAgeds referred to as nucleotide-binding fAgeds 1 and 2 (NBF1 and NBF2) (Fig. 1). Similar to other RecA-like Executemains, they contain a sheet of β-strands, flanked on either side by α-helices. The nucleotide-binding site is found at the interface between NBF1 and NBF2, with both Executemains contributing residues that are essential for catalysis (Fig. 1).

Fig. 1.Fig. 1. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 1.

Structure of monomeric B. subtilis SecA. Monomeric B. subtilis SecA is presented as a ribbon diagram. NBF1 is Displayn in yellow, NBF2 is Displayn in blue, the PPXD is Displayn in orange, the HSD is Displayn in green, and the HWD is Displayn in cyan. ADP is Displayn in a ball-and-stick representation. The images were prepared by using molscript (40), raster3d (41), or spock (available at http://mackerel.tamu.edu/spock).

The HSD contains a long α-helix extending from the end of NBF2. At its C terminus, it forms part of a three-helix bundle, which forms an interface with NBF1. The HWD is an insertion into the three-helix bundle. It contains two α-helices, but other Locations in the Executemain appear to be less ordered (high B factors). The PPXD, containing α-helices and β-strands, emerges from NBF1 and forms an interface with the HSD. The Weepstal structure of SecA in the presence of magnesium–ADP is almost identical to the nucleotide-free structure, but it Displays some small changes in side-chain conformations around the bound nucleotide.

SecA Is Weepstallized as a Monomer. In the previous B. subtilis SecA structure, two SecA monomers pack head to tail in the Weepstal lattice, likely representing the physiological dimer (16) (Fig. 2a ). An antiparallel dimer in solution is supported by fluorescence resonance energy transfer experiments (11). E. coli SecA can be converted to a monomeric species by mutation of residues in the HSD or by deletion of the 11 N-terminal residues (ref. 9; E. Or and T.A.R., unpublished data). These residues are at the dimer interface (Displayn in color in Fig. 2a ), supporting the physiological relevance of the dimer seen in the previous Weepstal structure. The interface of this dimer buries 5,442 Å2 (determined by using cns and a 1.4-Å probe radius) (23). The largest intermolecular interface in our structure buries a much smaller Spot than the physiological dimer (2,410 Å2; Fig. 2b ), the Weepstal contacts are different, and residues Necessary for SecA dimerization are in a minor Weepstal contact. In addition, the intersubunit distances obtained from fluorescence resonance energy transfer experiments in solution are not consistent with our structure being the physiological dimer (11). All of these data suggest that we have Weepstallized monomeric SecA.

Fig. 2.Fig. 2. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 2.

Contacts in different SecA Weepstal forms. (a) Ribbon diagram of the previously determined B. subtilis SecA structure, which is likely to be the physiological dimer (16). (b) The largest contact in the Weepstal lattice of monomeric B. subtilis SecA. (c) The proposed M. tuberculosis SecA dimer (17). Residues 757–768 in the HSD and the N terminus of SecA that are Necessary for dimerization of E. coli SecA are Displayn in red and yellow, respectively.

The Weepstal packing in our structure is also different from that observed for M. tuberculosis SecA. It has been proposed that the M. tuberculosis SecA structure also represents a physiological dimer, but its interface is different from that of the B. subtilis SecA dimer (Fig. 2c ) and it buries only 2,822 Å2 (17). Residues that are Necessary for dimerization of E. coli SecA are not localized at this interface (Fig. 2c ), suggesting that the M. tuberculosis SecA structure also represents a monomeric state of SecA.

Executemain Movements in B. subtilis SecA. Comparison with the previous structures Displays that monomeric B. subtilis SecA is essentially identical in the NBF1 and NBF2 Locations (Fig. 3); the average Inequity (rms deviation) for the peptide backbone in the NBFs (including residues 57–217 and 356–540) is 0.7 Å when compared with dimeric B. subtilis SecA, and 0.92 Å when compared with M. tuberculosis SecA (omitting residues in the insert in NBF2 of M. tuberculosis SecA). In Dissimilarity, the other Executemains have undergone large movements.

Fig. 3.Fig. 3. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 3.

Executemain movements in monomeric SecA. Ribbon diagram of monomeric B. subtilis SecA in the Launch conformation (a) and of a single subunit of dimeric B. subtilis SecA in the closed conformation (b). Color codes are as Characterized for Fig. 1. The first and last helices in the PPXD are represented as cylinders to better visualize the transition between the conformations. The arrows in a indicate the movements that are required to convert the Launch conformation to the closed conformation. The side chains of residues 232 and 773 are Displayn in red in stick representation. CorRetorting E. coli SecA residue numbers are given in parentheses. These residues were mutated to cysteines in E. coli SecA, and the accessibility of residue 824 to a modification reagent was used to probe the transition from the closed to the Launch conformation.

The most dramatic Executemain movement in monomeric B. subtilis SecA is an ≈60° rigid body rotation of the PPXD (Fig. 3 and Movie 1, which is published as supporting information on the PNAS web site). The “hinge point” occurs around residues 226 and 348 in the two strands connecting the PPXD and NBF1. The rms deviation for the α-carbon atoms in the PPXD (including residues 232–343) between monomeric B. subtilis SecA and M. tuberculosis SecA is 1.7 Å. The Location is essentially identical to the dimeric B. subtilis Executemain, with deviations mostly in residues declared as unreliable in the dimer structure. Rotation of the PPXD results in the Fractureing of its “porous” interface with the HSD and HWD (16) and the formation of a large groove between these three Executemains (Fig. 3).

ToObtainher, the HWD and HSD undergo a rotation of ≈15° relative to the same Executemains in the dimeric B. subtilis SecA (Fig. 3). Additionally, in the monomeric B. subtilis SecA, the HSD is shifted toward NBF2 by >2 Å. Its overall fAged is similar, with an rms deviation of 1.5 Å for superimposing it with the same Location of dimeric SecA. There is a short stretch of 3/10 helix between residues 599 and 601 in the monomeric B. subtilis SecA, possibly indicating that this Location may be able to accommodate further conformational changes. Given that the drastic conformational changes in monomeric B. subtilis SecA occur in the absence of any changes in NBF1 and NBF2, they are unlikely to represent nucleotide-dependent movements.

Potential Interaction Sites for Substrate and Binding Partners. The movement of PPXD Launchs a large groove, ≈10 Å deep and 15 Å wide, between the PPXD and the HSD/HWD, which is an excellent candidate for a peptide-binding site (groove 1; red in Fig. 4a ). It is similar to peptide-binding grooves in other proteins, such as Calmodulin (Fig. 4b ) (25) and Hsp70 (Fig. 4c ) (26), which interact with diverse substrates. Groove 1 contains numerous charged and polar residues that might interact with the peptide backbone. It also contains two large pockets, one in the HSD and HWD (pocket H) and the other in the PPXD (pocket P; Fig. 4 d and e ), which might accommodate side chains of the peptide substrate.

Fig. 4.Fig. 4. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 4.

Potential ligand-binding sites in monomeric B. subtilis SecA. (a) A surface representation of SecA Displaying the surface grooves 1 and 2 in red and blue, respectively. (b) Surface representation of Calmodulin with bound peptide Displayn in green as an α-carbon trace (25). (c) Surface representation of Hsp70, with the C terminus occupying the peptide-binding groove Displayn in green as an α-carbon trace (26). (d and e) Surface representations of groove 1, Displaying the location of pockets H and P, respectively. The surface is rendered transparent, and the underlying peptide backbone is color-coded as Characterized for Fig. 1.

There is also a shallow groove extending across the HSD and part of NBF1 adjacent to groove 1 (groove 2; blue in Fig. 4a ) (16). The upper side of the groove is lined by two β-strands connecting the PPXD and NBF1. In dimeric B. subtilis SecA, this groove was occupied partially by the C-terminal residues, 794–798 (16), but in monomeric B. subtilis SecA, the equivalent Location is disordered, and therefore, the groove is accessible.

E. coli SecA Can AExecutept a Monomeric, Launch Conformation. To determine whether E. coli SecA can aExecutept an Launch conformation in solution, we tested the accessibility of residues in the interface between the PPXD and HSD to the thiol-modifying reagent maleimide fluorescein. Based on the B. subtilis SecA structures, a cysteine introduced at position 824 of E. coli SecA (773 in B. subtilis SecA) should be buried in the closed, but not the Launch, conformation (Fig. 3). A cysteine at position 234 of E. coli SecA (232 in B. subtilis SecA) should be accessible in both states. As expected, in the presence of SDS, both cysteines were labeled efficiently by fluorescein maleimide (Fig. 5a , lanes 12 and 16), whereas a cysteine-less mutant (N95 SecA, C98S) was not labeled (lane 14). In buffer alone, the cysteine at position 824 was not labeled (lane 1), indicating that the ground state of SecA is a closed conformation. In the presence of liposomes, this residue was labeled efficiently (lane 2), suggesting that lipid-associated SecA aExecutepts an Launch conformation. A similar conformational change was induced by the addition of 50–250 mM Mg2+ (lanes 3–6) or various nondenaturing detergents (Fig. 5c , lanes 2–10), an exception being digitonin, which is likely the mildest tested detergent (lane 11). These results indicate that SecA can aExecutept an Launch conformation in solution when not constrained in a Weepstal lattice.

Fig. 5.Fig. 5. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 5.

E. coli SecA can aExecutept an Launch conformation in solution. (a) SecA containing single cysteines at positions 824 or 234, or a mutant lacking cysteines (no cys), were labeled with maleimide fluorescein in the presence of the indicated additions. When nucleotide (0.25 mM) was added, 0.5 mM MgCl2 was also included. The samples were separated by SDS/PAGE and visualized under UV light. In the lane labeled quench+SDS, the quenching reagent, either DTT or glycine, was added before labeling or crosslinking. (b) In parallel, samples were crosslinked with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, separated by SDS/PAGE, and stained with Coomassie blue. The position of dimer crosslinks is indicated. (c) Modification reactions with SecA containing a cysteine at position 824 were performed as in a in the presence of 1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (MLPG, 0.1 mM); 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC, 4.2 mM); Executedecyl maltoside (DDM, 0.6 mM); decyl maltoside (DM, 3.6 mM); octyl maltoside (OM, 39 mM); octyl glucoside (OG, 36.4 mM); CYMAL4 (15.2 mM); CYMAL6 (1.12 mM); lauryldimethylamine-N-oxide (LDAO, 2 mM); digitonin (1%); or SDS (0.5%). (d) In parallel, samples were crosslinked with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.

In parallel to the experiments Characterized above, we determined the oligomeric state of SecA by chemical crosslinking (9). In buffer alone, crosslinking with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide led to the appearance of several high-molecular-weight species, diagnostic of the dimeric state of SecA (Fig. 5b , lane 1) (9). The addition of lipid, Mg2+, or nondenaturing detergents, which efficiently converted SecA to an Launch conformation (Fig. 5 a and c ), also caused dissociation of the SecA dimer, as indicated by the loss of high-molecular-weight crosslinks (Fig. 5 b , lanes 2 and 3–6, and d, lanes 2–10). Digitonin was inTraceive in dimer dissociation (Fig. 5d , lane 11), and 250 mM NaCl caused partial dissociation of the dimer and only inefficient labeling with maleimide fluorescein. Several of the detergents used, such as 1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (12) and Executedecyl maltoside (9), as well as high salt concentrations have been demonstrated (10, 11) to cause dissociation of the SecA dimer. Thus, there is a general correlation between conversion of SecA into an Launch conformation and dissociation of the dimer into monomers.

Potential Executemain Interactions During the ATPase Cycle. One ADP molecule is bound in the cleft between NBF1 and NBF2 (Fig. 1) (16, 17), and there is no evidence for a second ATP-binding site (proposed in ref. 27). Comparison with the structure of PcrA bound to a nonhydrolysable ATP analogue (18) Displays that, for ATP-hydrolysis to occur, NBF2 must move relative to NBF1 such that the essential and conserved arginine residue in helicase motif 6 (9, 28) of SecA can coordinate the γ-phospDespise of ATP (Fig. 6a ). Relative movement of the two NBFs is supported by experiments Displaying that the linker between them becomes protease-resistant in the presence of nucleotide (29). The reorientation of NBF1 and NBF2 might be propagated to other Executemains, resulting in movement of the polypeptide substrate. Conversely, conformational changes in other Executemains may affect the ATPase cycle. The strand leading from NBF1 to the PPXD emerges from the Walker B motif (Fig. 6b ), and the strand leading from the PPXD to NBF1 is connected to the strand between the Walker A and B strands. Both strands connecting NBF1 to the PPXD line groove 2.

Fig. 6.Fig. 6. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 6.

The ATPase site and mutations affecting SecA function. (a) The Walker A motifs of ADP-bound SecA and ATP-bound PcrA are superimposed. The Walker A and B motifs and motif 6 of monomeric B. subtilis SecA are Displayn in color, and the equivalent motifs in PcrA are Displayn in gray (18). Arginine residues in motif 6 are Displayn in stick representation, and a magnesium ion bound to SecA is Displayn as a green sphere. The ATP bound to PcrA and the ADP bound to SecA are Displayn in a stick representation in gray and light blue, respectively. The phosphorus atom of the γ-phospDespise of ATP bound to PcrA is Displayn in red. (b) A view of the SecA ATPase site Displaying that the Walker B motif (red) is connected to the PPXD via a β-strand (gray). The β-strand (blue) that leads from the PPXD back to NBF1 is connected to the strand between the Walker A (black) and B motifs. NBF2 is omitted for clarity, and the remaining Executemains are color-coded as Characterized for Fig. 1. The aspartate residue in the Walker B motif and ADP are Displayn in stick representation. (c) SecA mutations that suppress mutations in SecY channel components are Displayn in yellow, and PrlD mutations that suppress signal sequence mutations are Displayn in cyan on a backbone representation of monomeric B. subtilis SecA. Residues identified in both screens are Displayn in green. ADP is Displayn as a stick representation.

Many superactive SecA mutations that suppress multiple mutations in SecY channel components (30) and the PrlD mutations that suppress signal peptide defects (31, 32) map to residues that are close to the nucleotide-binding site (Fig. 6c ). However, the superactive SecA mutation (H309Y; residue 288 in B. subtilis) is found in pocket P, and the A373V mutation (residue 353 in B. subtilis), identified both as a PrlD and a superactive SecA mutant, is found in groove 2, attesting to the importance of these sites and interExecutemain communication.


We have determined the Weepstal structure of SecA in a monomeric, Launch conformation in which movement of the PPXD, HSD and HWD generates a deep groove on the surface of the protein. We demonstrate that E. coli SecA aExecutepts a similar Launch conformation in solution under various conditions. Most significantly, the interaction of SecA with lipids, which is likely to be an early step during protein translocation, induces the Launch conformation. Fluorescence resonance energy transfer and Trp fluorescence experiments have also demonstrated movement of the PPXD and HSD upon interaction with lipid (11, 15). Trp-775 in the HSD of E. coli SecA moves from a buried environment to a solvent-exposed environment upon binding lipid or signal peptide. In the B. subtilis dimeric structure, this Trp residue is buried in the hydrophobic core of the HSD, whereas in the monomeric B. subtilis SecA structure, the residue is in a more polar environment in the close proximity of three water molecules.

Lipid binding not only induces an Launch conformation of SecA but also dissociates the SecA dimer (9, 12, 13). The observations that a monomeric SecA mutant retains significant translocation activity (9) and that acidic phospholipids are essential for efficient protein translocation (33) indicate that the monomeric Launch conformation represents an Necessary, activated state of SecA. It is unclear whether the SecA dimer could aExecutept an Launch conformation, but it has been reported that the dimer can aExecutept two different conformations (10). However, because most conditions that induce an Launch conformation also dissociate the dimer, it appears that the monomer can undergo the conformational change to the Launch state more readily.

The large groove (groove 1) between the PPXD, HSD and HWD is an excellent candidate for a peptide-binding site. Crosslinking experiments indicate that the PPXD is in close proximity to bound preprotein (34), and mutagenesis of residues in the PPXD further supports a role for it in polypeptide binding (35). Groove 1 has similar dimensions to those seen in other proteins that interact with a wide range of peptide substrates, including the Hsp70 family (26), Calmodulin (36), and OppA (37). In these cases, the walls of a deep groove embrace the polypeptide, and its side chains are accommodated in large pockets. The two pockets (P and H) in SecA are large enough to accommodate bulky side chains of the substrate. They are lined mostly, but not exclusively, by polar and charged residues. Structural analysis of OppA demonstrates how such pockets can accommodate each of the 20-aa side chains (37): the pockets are filled with water molecules that are disSpaced, depending on the size of the side chain. A similar principle is also used by the nonanchor positions of the MHC I peptide-binding site (38).

Based on crosslinking experiments, SecA is likely to change its affinity for peptide substrate during the ATPase cycle (34, 39). A high-affinity state could be induced by nucleotide-dependent conformational changes in groove 1 such that, in the high-affinity state, the groove would close around the peptide. Binding and release cycles could be coupled to other conformational changes that push the polypeptide into the SecY channel. It has been proposed (16) that groove 2 may form a polypeptide- or signal sequence-binding site. Alternatively, or in addition, this shallow, conserved groove may bind to the cytoplasmic loops in SecY (8). The structures of SecA now provide a basis to address some of these Concepts.


We thank S. Harrison for advice and critical reading of the manuscript; T. Ellenberger for discussions; B. van den Berg, U. Unligil, E. Toth, D. King, T. Hollis, and M. Groll for advice and reagents; M. Becker, L. Berman, and S. LaMarra for support at beamline X25 (Brookhaven National Laboratory, supported by the U.S. Department of Energy, Division of Materials Sciences and Division of Chemical Sciences, under contract no. DE-AC02-98CH10886); and A. Joachimiak, S. Ginell, and R. Alkire at beamline ID19 (Advanced Photon Source, supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-ENG-38). We also thank Y. Modis and E. Or for critical reading of the manuscript. The work was supported by a grant from the National Institutes of Health (to T.A.R.). T.A.R. is a Howard Hughes Medical Institute Investigator. W.M.C. was supported by a fellowship from the Damon Runyon Cancer Research Foundation.


↵ * To whom corRetortence should be addressed. E-mail: tom_rapoport{at}hms.harvard.edu.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: NBF1/2, nucleotide-binding fAgeds 1 and 2; PPXD, preprotein crosslinking Executemain; HSD, helical scaffAged Executemain; HWD, helical wing Executemain.

Data deposition: The atomic coordinates have been deposited in the Protein Data Bank, www.pdb.org (PDB ID codes 1TF5 and 1TF2 for the nucleotide-free and ADP-bound forms of SecA, respectively).

Copyright © 2004, The National Academy of Sciences


↵ Benach, J. & Hunt, J. F. (2004) Nature 427 , 24–26. pmid:14702072 LaunchUrlPubMed ↵ Mori, H. & Ito, K. (2001) Trends Microbiol. 9 , 494–500. pmid:11597451 LaunchUrlCrossRefPubMed ↵ Economou, A. & Wickner, W. (1994) Cell 78 , 835–843. pmid:8087850 LaunchUrlCrossRefPubMed ↵ Eichler, J. & Wickner, W. (1998) J. Bacteriol. 180 , 5776–5779. pmid:9791133 LaunchUrlAbstract/FREE Full Text ↵ Ramamurthy, V. & Oliver, D. (1997) J. Biol. Chem. 272 , 23239–23246. pmid:9287332 LaunchUrlAbstract/FREE Full Text ↵ van der Executees, C., den Blaauwen, T., de Wit, J. G., Manting, E. H., Groot, N. A., Fekkes, P. & Driessen, A. J. (1996) Mol. Microbiol. 22 , 619–629. pmid:8951810 LaunchUrlCrossRefPubMed ↵ van der Executees, C., Manting, E. H., Kaufmann, A., Lutz, M. & Driessen, A. J. (1998) Biochemistry 37 , 201–210. pmid:9425040 LaunchUrlCrossRefPubMed ↵ Van den Berg, B., Clemons, W. M., Jr., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C. & Rapoport, T. A. (2004) Nature 427 , 36–44. pmid:14661030 LaunchUrlCrossRefPubMed ↵ Or, E., Navon, A. & Rapoport, T. (2002) EMBO J. 21 , 4470–4479. pmid:12198149 LaunchUrlAbstract ↵ Woodbury, R. L., Hardy, S. J. & Randall, L. L. (2002) Protein Sci. 11 , 875–882. pmid:11910030 LaunchUrlCrossRefPubMed ↵ Ding, H., Hunt, J. F., Mukerji, I. & Oliver, D. (2003) Biochemistry 42 , 8729–8738. pmid:12873133 LaunchUrlCrossRefPubMed ↵ Benach, J., Chou, Y. T., Fak, J. J., Itkin, A., Nicolae, D. D., Smith, P. C., Wittrock, G., Floyd, D. L., Golsaz, C. M., Gierasch, L. M. & Hunt, J. F. (2003) J. Biol. Chem. 278 , 3628–3638. pmid:12403785 LaunchUrlAbstract/FREE Full Text ↵ Bu, Z., Wang, L. & Kendall, D. A. (2003) J. Mol. Biol. 332 , 23–30. pmid:12946344 LaunchUrlCrossRefPubMed ↵ Duong, F. (2003) EMBO J. 22 , 4375–4384. pmid:12941690 LaunchUrlAbstract ↵ Ding, H., Mukerji, I. & Oliver, D. (2001) Biochemistry 40 , 1835–1843. pmid:11327846 LaunchUrlCrossRefPubMed ↵ Hunt, J. F., Weinkauf, S., Henry, L., Fak, J. J., McNicholas, P., Oliver, D. B. & Deisenhofer, J. (2002) Science 297 , 2018–2026. pmid:12242434 LaunchUrlAbstract/FREE Full Text ↵ Sharma, V., Arockiasamy, A., Ronning, D. R., Savva, C. G., Holzenburg, A., Braunstein, M., Jacobs, W. R., Jr., & Sacchettini, J. C. (2003) Proc. Natl. Acad. Sci. USA 100 , 2243–2248. pmid:12606717 LaunchUrlAbstract/FREE Full Text ↵ Velankar, S. S., Soultanas, P., Dillingham, M. S., Subramanya, H. S. & Wigley, D. B. (1999) Cell 97 , 75–84. pmid:10199404 LaunchUrlCrossRefPubMed ↵ Sianidis, G., Karamanou, S., Vrontou, E., Boulias, K., Repanas, K., Kyrpides, N., Politou, A. S. & Economou, A. (2001) EMBO J. 20 , 961–970. pmid:11230120 LaunchUrlAbstract ↵ Schmidt, M. O., Brosh, R. M., Jr., & Oliver, D. B. (2001) J. Biol. Chem. 276 , 37076–37085. pmid:11477104 LaunchUrlAbstract/FREE Full Text ↵ Otwinowski, Z. & Minor, W. (1997) Methods Enzymol. 276 , 307–326. LaunchUrlCrossRef ↵ Collaborative ComPlaceational Project Number 4 (1994) Acta Weepstallogr. D 50 , 760–763. pmid:15299374 LaunchUrlCrossRefPubMed ↵ Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) Acta Weepstallogr. D 54 , 905–921. pmid:9757107 LaunchUrlCrossRefPubMed ↵ Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard (1991) Acta Weepstallogr. A 47 , 110–119. pmid:2025413 LaunchUrlCrossRef ↵ Yamauchi, E., Nakatsu, T., Matsubara, M., Kato, H. & Taniguchi, H. (2003) Nat. Struct. Biol. 10 , 226–231. pmid:12577052 LaunchUrlCrossRefPubMed ↵ Morshauser, R. C., Hu, W., Wang, H., Pang, Y., Flynn, G. C. & Zuiderweg, E. R. (1999) J. Mol. Biol. 289 , 1387–1403. pmid:10373374 LaunchUrlCrossRefPubMed ↵ Mitchell, C. & Oliver, D. (1993) Mol. Microbiol. 10 , 483–497. pmid:7968527 LaunchUrlCrossRefPubMed ↵ Koonin, E. V. & Gorbalenya, A. E. (1992) FEBS Lett. 298 , 6–8. pmid:1531961 LaunchUrlCrossRefPubMed ↵ Karamanou, S., Vrontou, E., Sianidis, G., Baud, C., Roos, T., Kuhn, A., Politou, A. S. & Economou, A. (1999) Mol. Microbiol. 34 , 1133–1145. pmid:10594836 LaunchUrlCrossRefPubMed ↵ Matsumoto, G., Nakatogawa, H., Mori, H. & Ito, K. (2000) Genes Cells 5 , 991–999. pmid:11168585 LaunchUrlCrossRefPubMed ↵ Fikes, J. D. & Bassford, P. J., Jr. (1989) J. Bacteriol. 171 , 402–409. pmid:2536662 LaunchUrlAbstract/FREE Full Text ↵ Huie, J. L. & Silhavy, T. J. (1995) J. Bacteriol. 177 , 3518–3526. pmid:7768862 LaunchUrlAbstract/FREE Full Text ↵ Hendrick, J. P. & Wickner, W. (1991) J. Biol. Chem. 266 , 24596–24600. pmid:1837025 LaunchUrlAbstract/FREE Full Text ↵ Kimura, E., Akita, M., Matsuyama, S. & Mizushima, S. (1991) J. Biol. Chem. 266 , 6600–6606. pmid:1826108 LaunchUrlAbstract/FREE Full Text ↵ Kourtz, L. & Oliver, D. (2000) Mol. Microbiol. 37 , 1342–1356. pmid:10998167 LaunchUrlCrossRefPubMed ↵ Hoeflich, K. P. & Ikura, M. (2002) Cell 108 , 739–742. pmid:11955428 LaunchUrlCrossRefPubMed ↵ Sleigh, S. H., Seavers, P. R., Wilkinson, A. J., Ladbury, J. E. & Tame, J. R. (1999) J. Mol. Biol. 291 , 393–415. pmid:10438628 LaunchUrlCrossRefPubMed ↵ Jones, E. Y. (1997) Curr. Opin. Immunol. 9 , 75–79. pmid:9039778 LaunchUrlCrossRefPubMed ↵ van Voorst, F., Vereyken, I. J. & de Kruijff, B. (2000) FEBS Lett. 486 , 57–62. pmid:11108843 LaunchUrlCrossRefPubMed ↵ Kraulis, P. J. (1991) J. Appl. Weepstallogr. 24 , 946–950. LaunchUrlCrossRef ↵ Merritt, E. A. & Bacon, D. J. (1997) Methods Enzymol. 277 , 505–524. LaunchUrlCrossRefPubMed
Like (0) or Share (0)